3635 results for «326»

Filter By

3635 results

Integrating FFRangio into your daily practice - Empowering wire-free insights

18 May 2023 – From EuroPCR 2023

In this session, dive into the world of FFRangio, from concept to clinical reality, and then analyze different cases in real practice to see how useful the physiology is, to try to understand why it is still so little used, and to learn how FFRangio could...

Integrating FFRangio

Management of PCI complications

16 May 2023 – From EuroPCR 2023

Listen to speakers explore the landscape of PCI complications, dissecting their impact, strategies for skillful management and ways to optimize patient outcomes. Advance your own understanding of this important problem and discover a range of approaches to mitigating it.

Management of PCI complications

Meaningful innovations in interventional cardiology

18 May 2023 – From EuroPCR 2023

In this session, watch the case of a 56-year-old man with HTN, DM, stable CAD, PFO and previous ischaemic stroke, who presented with severely calcified CTO lesion on proximal LAD and significant mid-RCA lesion, and find out how he was treated LIVE... among others!

Meaningful innovations

MedAlliance SELUTION SLR is the first DEB to receive coronary de novo IDE Aapproval , its Fourth FDA IDE DEB approval

10 Jan 2023

Over 1,000 patients enrolled in landmark SELUTION DeNovo study

14 Mar 2023

MedAlliance to be acquired by Cordis

18 Oct 2022

MedAlliance SELUTION SLR Receives Coronary FDA IDE Approval

24 Oct 2022

MedAlliance leads US Sirolimus DEB race: first US patient enrolled into SELUTION SLR coronary sirolimus DEB study

25 Jan 2023

MedAlliance acquired by Cordis for up to USD 1.135 billion

02 Oct 2023

MedAlliance announces enrollment of over 1,660 patients in landmark SELUTION DeNovo study

14 Sep 2023

POPular TAVI - Antithrombotic Therapy After Transcatheter Aortic Valve Implantation in Patients With a Long-Term Indication for Oral Anticoagulation

04 Apr 2020

The POPular TAVI trial is an open label randomized study designed to evaluate oral anticoagulation (OAC) alone compared with OAC plus clopidogrel for 3 months in patients undergoing transcatheter aortic valve replacement (TAVR) with a long-term indication for oral anticoagulation. Those who had undergone percutaneous revascularization...

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
Primary endpoint of All Bleeding

Why hypertension is a major unresolved problem

02 Oct 2024

Explore the global challenge of hypertension, affecting one in three adults, and the strategies for screening, diagnosis, and management, including lifestyle modifications, pharmacotherapy, and device-based treatments, as outlined by Sofie Brouwers.

Sofie Brouwers

Author

Sofie Brouwers
Why hypertension is a major unresolved problem

RENOVATE-COMPLEX-PCI: Intravascular imaging-guided versus angiography-guided procedural optimization in complex percutaneous coronary intervention

06 Mar 2023

Daniele Giacoppo reports the main results of the RENOVATE-COMPLEX-PCI trial presented by Joo-Yong Hahn, from the Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea, in a Late-Breaking Trial session at the American College of Cardiology (ACC) 2023 / World...

Daniele Giacoppo

Author

Daniele Giacoppo
RENOVATE-COMPLEX-PCI: Intravascular imaging-guided versus angiography-guided procedural optimization in complex percutaneous coronary intervention

Biocardia receives FDA breakthrough device designation for CardiAMP Cell Therapy System for heart failure

03 Feb 2022

Surgical left atrial appendage occlusion in VHD without AF: OPINION Trial

03 Sep 2025

Alex Sticchi provides his take on the results of the OPINION trial presented by Yang Wang at the ESC Congress 2025 in Madrid.

Alessandro Sticchi

Author

Alessandro Sticchi
OPINION Trial: 1-year outcomes
Didn’t find what you were looking for?